FDA Commissioner Scott Gottlieb's recent remark that the agency's review of tobacco product applications was never the agency's best way to deal with youth-use of tobacco has reignited debate over the agency's strategy for stemming youth tobacco use. The remarks have also raised questions as to how much weight FDA must give to risks of young people initiating tobacco use when weighing a product's potential benefits and risks, as required under the Tobacco Control Act. The agency has faced increased...